Firdapse
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
69616-211 -
Package NDC
69616-211-03 -
Package NDC
69616-211-06 -
Package NDC
69616-211-08 -
Application number
NDA208078 -
SPL ID
4f94edd2-b6a8-264d-e063-6294a90a89df -
SPL set ID
f015fe60-3128-4a43-8c31-19fc6b5def3f -
UNII
8HF8FIN815 -
RxCUI
2106343 -
RxCUI
2107518
What the source publishes
- Labeler
- Catalyst Pharmaceuticals, Inc.
- Active ingredients
- amifampridine phosphate
- Form
- TABLET
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- NDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Firdapse",
"splId": "4f94edd2-b6a8-264d-e063-6294a90a89df",
"labels": [
{
"setId": "f015fe60-3128-4a43-8c31-19fc6b5def3f",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f015fe60-3128-4a43-8c31-19fc6b5def3f",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f015fe60-3128-4a43-8c31-19fc6b5def3f"
}
],
"routes": [
"ORAL"
],
"labeler": "Catalyst Pharmaceuticals, Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "240 TABLET in 1 BOTTLE, PLASTIC (69616-211-03)",
"package_ndc": "69616-211-03",
"identifierStatus": "well-formed",
"marketing_start_date": "20190107"
},
{
"sample": false,
"description": "12 BLISTER PACK in 1 CARTON (69616-211-06) / 10 TABLET in 1 BLISTER PACK (69616-211-04)",
"package_ndc": "69616-211-06",
"identifierStatus": "well-formed",
"marketing_start_date": "20190107"
},
{
"sample": false,
"description": "60 TABLET in 1 BOTTLE, PLASTIC (69616-211-08)",
"package_ndc": "69616-211-08",
"identifierStatus": "well-formed",
"marketing_start_date": "20190107"
}
],
"productId": "69616-211_4f94edd2-b6a8-264d-e063-6294a90a89df",
"useDomain": "unknown",
"dosageForm": "TABLET",
"productNdc": "69616-211",
"deaSchedule": null,
"genericName": "amifampridine phosphate",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "AMIFAMPRIDINE PHOSPHATE",
"strength": "10 mg/1"
}
],
"applicationNumber": "NDA208078",
"marketingCategory": "NDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20190107",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"unii": [
"8HF8FIN815"
],
"rxcui": [
"2106343",
"2107518"
],
"spl_set_id": [
"f015fe60-3128-4a43-8c31-19fc6b5def3f"
],
"manufacturer_name": [
"Catalyst Pharmaceuticals, Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:69616-211_4f94edd2-b6a8-264d-e063-6294a90a89df"